dc.contributor.author | Balik, Emre | |
dc.contributor.author | Okyar, Alper | |
dc.contributor.author | Gural, Zeynep | |
dc.contributor.author | Cipe, Gokhan | |
dc.contributor.author | Kilickap, Sadettin | |
dc.contributor.author | YILDIZ, ŞEYMA | |
dc.contributor.author | Kaytan-Saglam, Esra | |
dc.contributor.author | Akgun, Zuleyha | |
dc.contributor.author | Saglam, Sezer | |
dc.contributor.author | YÜCEL, Serap | |
dc.date.accessioned | 2021-03-04T08:47:34Z | |
dc.date.available | 2021-03-04T08:47:34Z | |
dc.date.issued | 2014 | |
dc.identifier.citation | Akgun Z., Saglam S., YÜCEL S., Gural Z., Balik E., Cipe G., YILDIZ Ş., Kilickap S., Okyar A., Kaytan-Saglam E., "Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study", CANCER CHEMOTHERAPY AND PHARMACOLOGY, cilt.74, sa.4, ss.751-756, 2014 | |
dc.identifier.issn | 0344-5704 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_65125812-f31e-446b-8171-64a2c1d1fcf9 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/70292 | |
dc.identifier.uri | https://doi.org/10.1007/s00280-014-2558-x | |
dc.description.abstract | The aim of this study was to evaluate efficacy and safety of chronomodulated capecitabine administered according to a specific time schedule (Brunch Regimen: Breakfast and Lunch) as a part of neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer. | |
dc.language.iso | eng | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Onkoloji | |
dc.subject | Eczacılık | |
dc.subject | Temel Eczacılık Bilimleri | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Temel Bilimler | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.subject | FARMAKOLOJİ VE ECZACILIK | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ONKOLOJİ | |
dc.title | Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study | |
dc.type | Makale | |
dc.relation.journal | CANCER CHEMOTHERAPY AND PHARMACOLOGY | |
dc.contributor.department | Bezmiâlem Vakıf Üniversitesi , Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü | |
dc.identifier.volume | 74 | |
dc.identifier.issue | 4 | |
dc.identifier.startpage | 751 | |
dc.identifier.endpage | 756 | |
dc.contributor.firstauthorID | 70473 | |